Error processing SSI file
NEWS RELEASE 99-044; APRIL 5, 1999 April 5, 1999
News Release 99-044
Inv. No. 332-402

ITC RELEASES ADVICE CONCERNING
THE ELIMINATION OF DUTIES ON CERTAIN PHARMACEUTICAL PRODUCTS
AND CHEMICAL INTERMEDIATES

The U.S. International Trade Commission (ITC) today released its report Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States.

The ITC, an independent, nonpartisan, factfinding federal agency, prepared the report at the request of the United States Trade Representative.

As part of the Uruguay Round Agreements, the United States and 21 other major trading countries negotiated the reciprocal elimination of duties on approximately 7,000 pharmaceutical products and chemical intermediates (used for the production of pharmaceuticals), as well as certain derivatives of the pharmaceutical products. As of January 1, 1995, these products, enumerated in the Pharmaceutical Appendix to the HTS, have been eligible to enter the United States free of duty.

The 22 countries also agreed to conduct a review, at least once every 3 years, to identify further products that could be covered by the pharmaceutical duty elimination initiative. The first review resulted in the addition of 496 items to the Pharmaceutical Appendix, implemented on April 1, 1997. Participants, including the United States, have undertaken a second review, which has resulted in the 642 items included in this investigation.

In its report, the ITC, as requested, provided a summary description of the products contained in the existing Pharmaceutical Appendix and the proposed modifications to that Appendix; an explanation of the relationship between the various elements of the Pharmaceutical Appendix and the Harmonized Tariff Schedule of the United States (HTS); and estimates of U.S. imports and, where possible, U.S. exports of the products included in the existing Pharmaceutical Appendix and the proposed additions to the Appendix, based on product groupings as necessary.

The ITC's report Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States (Inv. No. 332-402, USITC Publication 3167, April 1999) will be posted on the ITC's Internet server at www.usitc.gov. A printed copy may be requested by calling 202- 205-1809 or by writing the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Requests may be faxed to 202-205-2104.

-- 30 --